Evermay Wealth Management’s Gilead Sciences GILD Stock Holding History

Evermay Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-148	Closed	-$18.2K	–	607
2025 Q4	$18.2K	Hold	148	–	–	﹤0.01%	397
2025 Q3	$16.4K	Sell	148 -2	-1%	-$227	﹤0.01%	406
2025 Q2	$16.6K	Hold	150	–	–	﹤0.01%	400
2025 Q1	$16.8K	Hold	150	–	–	﹤0.01%	402
2024 Q4	$13.9K	Hold	150	–	–	﹤0.01%	406
2024 Q3	$12.6K	Hold	150	–	–	﹤0.01%	438
2024 Q2	$10.3K	Hold	150	–	–	﹤0.01%	451
2024 Q1	$11K	Sell	150 -11	-7%	-$846	﹤0.01%	458
2023 Q4	$13K	Buy	161 +11	+7%	+$856	﹤0.01%	427
2023 Q3	$11.2K	Hold	150	–	–	﹤0.01%	414
2023 Q2	$11.6K	Hold	150	–	–	﹤0.01%	413
2023 Q1	$12.4K	Hold	150	–	–	﹤0.01%	397
2022 Q4	$12.9K	Hold	150	–	–	﹤0.01%	394
2022 Q3	$9K	Hold	150	–	–	﹤0.01%	405
2022 Q2	$9K	Hold	150	–	–	﹤0.01%	406
2022 Q1	$9K	Hold	150	–	–	﹤0.01%	426
2021 Q4	$11K	Hold	150	–	–	﹤0.01%	399
2021 Q3	$10K	Hold	150	–	–	﹤0.01%	382
2021 Q2	$10K	Buy	+150	New	+$10K	﹤0.01%	408

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Evermay Wealth Management's GILD Position: Q1 2026 in Review

Evermay Wealth Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 148 shares — an estimated $18.2K sold.

Evermay Wealth Management first reported a position in GILD in Q2 2021 and held it in 19 quarters. The position peaked at $18.2K in Q4 2025. 2,329 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Evermay Wealth Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Evermay Wealth Management sold 148 Gilead Sciences shares in Q1 2026, an estimated $18.2K.
Evermay Wealth Management first reported a position in Gilead Sciences in Q2 2021 and held it in 19 quarters.
Evermay Wealth Management's Gilead Sciences position peaked at $18.2K in Q4 2025.
2,329 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.